Top Undervalued Medical - Diagnostics & Research industry Stocks 2026

Qiagen (QGEN) is the most undervalued stock in the Medical - Diagnostics & Research industry with an estimated 28.5% upside, followed by Charles River Laboratories International, (CRL) at 19.2% and IQVIA Holdings (IQV) at 14.7%.

Updated todayBased on intrinsic value modelsIndustry: Medical - Diagnostics & Research

Page snapshot: 18 July 2026, 11:26 pm

View full analysis in the screener → · All undervalued →

Before you trade on valuation alone

Cross-check fair value with fundamentals, liquidity, and your own goals—this table is a screen, not advice.

Check if a stock is undervalued See intrinsic value →

Medical - Diagnostics & Research Industry Valuation Insights (Updated Today)

The Medical - Diagnostics & Research industry currently shows an average upside of 20.8% on this snapshot.
Top name Qiagen N.V. (QGEN) trades at roughly a 28.5% discount to modeled intrinsic value—rankings move with prices and inputs.

Undervalued Medical - Diagnostics & Research Stocks by Market Cap

Large cap (top 5)

1.Charles River Laboratories International, Inc. · CRL19.2%$10.81B
2.IQVIA Holdings Inc. · IQV14.7%$34.42B

Mid cap (top 5)

1.Qiagen N.V. · QGEN28.5%$8.49B

Small cap (top 5)

No qualifying names in this bucket on this snapshot.

What Are Undervalued Medical - Diagnostics & Research Stocks?

Undervalued medical - diagnostics & research stocks are names where price sits below modeled fair (intrinsic) value—often expressed as positive headline upside versus the current quote.

This is not a buy list. Validate each symbol on its company page before you act.

How We Identify Undervalued Medical - Diagnostics & Research Stocks

We pull an industry-filtered undervalued snapshot (price, intrinsic value, upside, cap, sector, country) and rank by headline upside. You can sort and search in the table above.

Rankings can shift intraday as prices and model inputs move. Use the stock screener for custom filters beyond this industry leaderboard.

FAQs

Answers about undervalued medical - diagnostics & research names, intrinsic value, and how often this list refreshes.

What are undervalued medical - diagnostics & research stocks?

They are Medical - Diagnostics & Research names trading below modeled intrinsic value—shown here as upside % versus price. Models vary; use this as a screen, not advice.

How do you find undervalued medical - diagnostics & research stocks?

We load undervalued names for this industry from our API, then rank and filter in the table. Sort columns and open company pages to dig deeper.

Why are medical - diagnostics & research stocks undervalued?

Often sentiment, earnings, cycles, rates, or stock-specific news—not always a “misprice.” Intrinsic value is model-dependent.

Are undervalued medical - diagnostics & research stocks a good investment?

Not by label alone. Discounts can reflect risk or data lag. Check fundamentals and your goals; seek professional advice if needed.

How often is this list updated?

The page rebuilds on a schedule (ISR). Live quotes can move faster—use company pages for the latest.